1.89

5.59% 0.10

After Hours: 1.89

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $1.89, with a volume of 950.95K. It is up +5.59% in the last 24 hours and up +6.18% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$1.79

Open:

$1.79

24h Volume:

950.95K

Relative Volume:

2.22

Market Cap:

$184.72M

Revenue:

$32.38M

Net Income/Loss:

$-21.64M

P/E Ratio:

-7.5089

EPS:

-0.2517

Net Cash Flow:

$-13.78M

1W Performance:

+9.25%

1M Performance:

+6.18%

6M Performance:

-25.88%

1Y Performance:

-14.09%

1-Day Range:

$1.7701

$1.915

1-Week Range:

$1.67

$1.915

52-Week Range:

$1.59

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1100)

Industry

Medical Instruments & Supplies (56)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2026-08-06

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	1.89	168.11M	32.38M	-21.64M	-13.78M	-0.2517
ISRG Intuitive Surgical Inc	432.83	140.84B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	155.54	41.70B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	42.75	33.35B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	68.33	32.72B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	218.40	28.27B	5.54B	1.52B	1.74B	10.37

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-25	Initiated	Citizens JMP	Mkt Outperform
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

Jul 01, 2026

Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan

Jul 01, 2026

Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan

Jul 01, 2026

Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan

Jul 01, 2026

Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union

Jul 01, 2026

Jun 29, 2026

Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance

Jun 29, 2026

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView

Jun 29, 2026

Jun 28, 2026

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026

Enterprise value to revenue forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView

Jun 26, 2026

Price to sales forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView

Jun 26, 2026

Stereotaxis, Inc. Actuals & Estimates (AMEX:STXS) - TradingView

Jun 26, 2026

Jun 25, 2026

Stereotaxis, Inc. Actuals & Estimates (DUS:RJR1) - TradingView

Jun 25, 2026

STXS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 23, 2026

Stereotaxis | 4: Statement of changes in beneficial ownership of securities-Officer Peery Kimberly R. - Moomoo

Jun 23, 2026